Over 30,000 people are diagnosed with thyroid cancer each year in the United States, and the incidence of the disease has been rising by about 7 percent annually. However, it is one of the most curable cancers, with more than 90 percent of all thyroid cancers being successfully treated. In fact, the cure rate for many thyroid cancers approaches 99 percent.
At the Perlmutter Cancer Center, endocrine surgeons have an exceptional amount of surgical experience performing thyroidectomy (surgical removal of the thyroid, the primary treatment for thyroid cancer), performing more than 100 operations each year for thyroid cancer. This high surgical volume increases their experience treating the disease and their knowledge of its behavior.
Thyroid surgeons are part of NYU’s dedicated Division of Endocrine Surgery, established in 2007 to provide comprehensive care to patients requiring surgery for thyroid cancer, other thyroid conditions, hyperparathyroidism, and other endocrine tumors. The Division of Endocrine Surgery is also committed to the development of new clinical programs, clinical and translational research, and the education of residents and fellows in this rapidly growing subspecialty of surgery.
Thyroid cancer experts meet monthly in a multidisciplinary conference that brings together endocrinologists, surgeons, nuclear medicine specialists, and pathologists. Whether you are seeking a second opinion or are ready to start treatment, we encourage you to see one of our specialists to learn about your diagnostic and treatment options and make an informed decision about your care.